L ong-term studies of segmental pulmonary vein isolation for atrial fibrillation (AF) show that recurrences were very common after a single procedure, and arrhythmia-free survival rates were <40% after at least 1-year follow-up. 1 Wider isolation techniques that also isolated the pulmonary vein antra (wide antral isolation [WAI]) reduced recurrences compared with segmental isolation. 2 More recently, ablation lesion sets that also isolated the posterior left atrium have been developed, because the posterior left atrium is thought to play a role in the genesis and maintenance of AF. 3-6 Our first hypothesis was that single-ring isolation (SRI) of the posterior left atrium and pulmonary veins would result in lower AF and all arrhythmia recurrence rates compared with WAI.
tachyarrhythmias (OAT). These are often mitral annular reentrant atrial flutters. [10] [11] [12] Therefore, a mitral isthmus line (MIL) may be effective in reducing OAT recurrences when used with SRI or WAI. [10] [11] [12] Therefore, an MIL may be effective in reducing OAT recurrences when used with SRI or WAI. However, the efficacy of additional MIL ablation in SRI is unknown. Our second hypothesis was that additional MIL ablation would result in fewer AF and all arrhythmia recurrences compared with no MIL.
To address these hypotheses, a randomized trial was conducted to compare the efficacy and safety of WAI of the pulmonary veins with SRI of the pulmonary veins and the posterior left atrium, with or without additional MIL ablation.
Methods
The study cohort consisted of 220 consecutive patients who were referred for catheter ablation for drug-refractory and highly symptomatic AF. They were block-randomized (1:1) to have either WAI of the pulmonary veins as ipsilateral pairs ( Figure 1A and 1B) or SRI of the posterior left atrium and pulmonary veins ( Figure 1C and 1D). These 2 pulmonary vein isolation techniques have been previously described and are detailed in the online-only Data Supplement. 3, 10 Within each group, half of the patients were also randomly assigned to have empirical MIL ablation or no MIL ablation unless they had mitral isthmus-dependent flutter during the procedure, resulting in a 2×2 factorial study design.
Patients were excluded if they were <18 years of age, had previous left atrial ablation procedures, or were unable to give informed consent.
Procedure
WAI was performed by isolating ipsilateral vein pairs with a ring of ablation lesions ≈5 to 10 mm from the vein ostia ( Figure 1A and 1B). A roofline was also included linking the superior portions of the 2 rings. In patients randomized to SRI, the pulmonary veins and the posterior left atrium between them were isolated with a single ring of ablation lesions ( Figure 1C and 1D ). For both techniques, the procedural end point of electric isolation of the region within the rings of ablation lesions was defined as dissociated electric activity or the absence of electric activity during sinus rhythm or coronary sinus pacing and failure to capture the rest of the atria during pacing of the region within the ring of lesions with local capture. MIL ablation was performed in a similar manner for both WAI and SRI patients. A line of ablation lesions was made from the segment of the ring of ablation lesions adjacent to the left inferior pulmonary vein down to the mitral annulus. The end point was an electrically intact line of ablation as determined by differential pacing around the mitral annulus. If a patient, who was assigned to no MIL ablation, had inducible or spontaneous mitral annular atrial flutter, MIL ablation was also performed.
Please see the online-only Data Supplement for details of the procedure and postprocedural care.
Follow-Up
All patients were seen at 3, 6, and 12 months after procedure routinely and then 6 months thereafter. A 7-day Holter monitor was performed at 6 and 12 months. A 3-month blanking period was used, and a recurrence was defined as any atrial arrhythmia documented on ECG or Holter monitoring >30 seconds in duration. 13
Statistical Analysis
The prespecified primary end points of this study were AF-free survival after a single procedure and OAT-free survival after a single procedure. Secondary end points include survival free of any atrial arrhythmia and complication rates. The current consensus is to use freedom from any atrial tachyarrhythmia as primary end points in studies of AF ablation. This was not used in this study because the trial was conceived and began recruiting in 2006 before the publication of the current consensus guidelines. 13 However, we did prespecify survival free of any atrial tachyarrhythmia as a secondary end point.
The sample size calculation was based on an AF recurrence rate of 50% in the control arm and 70% in the treatment arm (a constant hazard ratio of 1.943) at 1 year, which was the minimum predefined follow-up period for patients in this study, with an α value of 0.05 and power of 0.80 which required a sample size of 96 in each arm. This calculation was based on our prediction that there would be much less than 10% censoring of patients (which is because of patients reaching their last follow-up with no recurrences of AF and OAT). We rounded Continuous variables are expressed as mean±SD unless they have a non-normal distribution, in which case they are expressed as median (interquartile range). Survival estimates are expressed as estimate % (95% CI). Analysis was performed on SPSS version 14 (SPSS Inc, Chicago, IL). Continuous dependent variables at a single time point were analyzed using the Student t test. Survival data were analyzed using Cox regression and Kaplan-Meier analysis with the log-rank test. All analyses were by intention to treat. P<0.05 was considered significant for all analyses.
Ethics
This study was conducted with the approval of and under the supervision of the Sydney West Area Health Service Human Research Ethics Committee and was registered with the Australia New Zealand Clinical Trials Registry.
Results

Baseline Characteristics
The baseline characteristics of the study cohort are shown in Table  1 . The mean age of the study cohort was 58±10 years, and 180 (82%) were men. AF was paroxysmal in 135 (61%), persistent in 85 (39%; including 37 [17%] with longstanding persistent AF), 13 and had been present for 5.5 years (interquartile range, 2.7-10.6 years). Please see the online-only Data Supplement for more details.
Procedure
Procedural variables are shown in Table 2 . The posterior left atrium and pulmonary veins were successfully isolated in all but one SRI patients, whereas the right pulmonary veins could not be isolated in one WAI patient and the left pulmonary veins were not isolated in another. Block across the roofline in WAI patients was also confirmed in all patients except one, who had also failed isolation of the right pulmonary veins. SRI patients had similar total ablation and procedure times compared with WAI patients. Patients randomized to MIL ablation had longer total ablation times, but fluoroscopy times were significantly shorter ( Table 2 ). The mean ablation time for the MIL was 11.9±7.0 minutes. Complete electric block across the MIL was confirmed in 64 (54%) of the 119 patients who had MIL ablation attempted. 
Survival Analysis
During a median of 2.2 (interquartile range, 1.6-3.1) years of follow-up, 1 patient was lost to follow-up. Follow-up for censored patients was 2.2 (1.5-3.1) years, whereas it was 2.2 (1.8-3.1) years among patients who experienced events (P=0.676).
No patients underwent a second procedure during the blanking period. Nine patients randomized not to have mitral isthmus ablation were crossed over to having ablation because they had inducible or spontaneous mitral isthmus-dependant flutter ( Table 2) . We analyzed all patient outcomes by intention to treat and also in an on-treatment manner and found that the results were similar. Hence, only the former analyses are presented here. In the first year after their procedure, there were only 2 censored patients (0.9%; at 244 and 355 days) in the survival analyses.
There was no significant interaction between the 2 randomly allocated variables for AF-free survival (P=0.462), OAT-free survival (P=0.108), or atrial arrhythmia-free survival (P=0.613). With Kaplan-Meier analysis, SRI patients had significantly fewer AF recurrences compared with WAI patients (Figure 2A ), and this effect was most marked among patients who did not have MIL ablation ( Figure 3A; 2-year AF-free survival: 76% [63%-86%] versus 49% [35%-62%]; P=0.007). Additional MIL ablation did not improve AF-free survival at 2 years for the whole cohort ( Figure 2B ), but the improvement in AF-free survival when combined with WAI only approached statistical significance ( Figure 3A; 2-year AF-free survival: 49% [35%-62%] for WAI versus 71% [57%-81%] for WAI with MIL; P=0.068). Cox regression analysis showed that adjusting for MIL ablation, SRI OAT recurrences were not significantly affected by isolation technique, with similar OAT-free survival at 2 years for SRI and WAI patients ( Figure 2C ). However, the change in organized atrial arrhythmia-free survival with MIL ablation approached statistical significance ( Figure 2D ). Furthermore, among SRI patients only, MIL ablation significantly reduced OAT recurrences ( Figure 3B; 2 Figure 3C ). Stratified and multivariate analysis showed that neither isolation technique nor MIL ablation affected atrial arrhythmia-free survival.
In patients who underwent WAI, successful mitral isthmus ablation with electric block, unsuccessful mitral isthmus ablation, or not having MIL ablation significantly influenced AF-free survival ( Figure 4A ) and atrial arrhythmia-free survival ( Figure 4C ) but not OAT-free survival ( Figure 4B ). Patients with intact MILs (complete electric block) had longer AF-free survival than patients who had unsuccessful ablation (P=0.001) and also longer atrial arrhythmia-free survival (P=0.010) but not less likely to have OAT-free survival (P=0.159). However, patients with incomplete MIL ablation had similar survival times compared with patients who did not have mitral isthmus ablation at all (AF: P=0.551; OAT: P=0.508; or any atrial arrhythmia: P=0.134).
In the group that underwent SRI, success at achieving electric block during mitral isthmus ablation did not significantly change survival at 2 years free of AF (68% [50%-81%]) compared with unsuccessful ablation (75% [53%-88%]; P=0.809) or no ablation (78% [64%-87%]; P=0.305). It also did not affect OAT-free survival compared with unsuccessful ablation (74% [56%-86%] versus 75% [53%-88%]; P=0.925) or no mitral isthmus ablation (56% [44%-71%]; P=0.096). Overall, survival free of any atrial tachyarrhythmia was similar in these 3 subgroups of patients (49% [31%-64%], 58% [36%-75%], and 51% [36%-63%], respectively; P=0.758). Among the 109 patients (56 had SRI and 53 had WAI) who remained free of atrial arrhythmia recurrences at the end of follow-up, 17 (16%; 4 [7%] SRI, 13 [25%] WAI; P=0.012) were continued on antiarrhythmic drug therapy at the discretion of their treating physician. This was later successfully discontinued in 2 patients with no further recurrences (1 SRI, 1 WAI).
In the subgroups of patients with paroxysmal AF or persistent AF, the SRI patients had nonsignificantly higher 2-year AF-free survival rates ( Figure 5A and 5B, respectively), but this approached statistical significance among paroxysmal AF patients (P=0.065).
Complications
Please see the online-only Data Supplement for further details.
Discussion
The main finding of this study is that SRI resulted in a different mode of recurrence characterized by longer AF-free survival than WAI on long-term follow-up but similar survival times free of recurrent OAT or recurrences of any atrial arrhythmia. The addition of MIL ablation also did not improve survival free of AF, but there was a tendency toward better OAT-free survival. This reached statistical significance in patients who had SRI. This study demonstrates that variations in the basic lesion set can have a significant impact on clinical outcomes and recurrence patterns.
SRI Results in Longer AF-Free Survival
Studies examining long-term results after pulmonary vein isolation have demonstrated high rates of recurrent arrhythmia after a single procedure. 1, 14, 15 Weerasooriya et al 1 found that, in a cohort of patients of whom 63% had paroxysmal AF (a proportion that is similar to the patients in the present study), arrhythmia-free survival rates after a single catheter ablation procedure were 40%, 37%, and 29% after 1, 2, and 5 years, respectively. 1 A recent meta-analysis of randomized studies found that wider isolation techniques had lower recurrence rates than ostial isolation in both paroxysmal and persistent AF patients. 2 One of the explanations proposed was that wider isolating lesions eliminate nonpulmonary vein sources of ectopic electric activity. 16 In particular, the posterior left atrium has been shown to be important for both the initiation and the maintenance of AF. 17, 18 In the present study, we have demonstrated that even wider isolation of the pulmonary veins enveloping the entire posterior left atrium resulted in even longer AF-free survival. These findings, combined with previous studies, demonstrate that the wider the isolation of the pulmonary veins the lower the subsequent risk of AF.
The findings are also consistent with studies reporting outcomes after surgical procedures for the treatment of AF. Surgical procedures for AF that include isolation of the pulmonary veins and the posterior left atrium as a key lesion have high success rates. 19 The isolation of the posterior left atrium may be particularly useful in patients with persistent or longstanding persistent AF because it seems to be more dependent on activity in the posterior left atrium than the pulmonary veins. 20, 21 However, in the present study we did not find differing effects of isolation technique in patients with paroxysmal or persistent AF.
Tamborero et al 5 recently reported that in a randomized comparison involving 120 patients of WAI with or without additional isolation of the posterior left atrium, there was no difference in arrhythmia-free survival after 9.8±4.3 months of follow-up. 5 However, this previous study differs from the current study in several ways. First, their cohort was smaller and was followed for a shorter period of time. Second, isolation was unsuccessful in 9% of patients in that study compared with 1% in the present study. Third, all patients received MIL ablation, although the efficacy of this in addition to SRI was uncertain. Finally, the authors did not distinguish between AF and OAT recurrences.
In this study, we found that SRI, which isolated the posterior left atrium in addition to the pulmonary veins, reduced AF recurrences compared with WAI, even after adjusting for the effect of MIL ablation. We also found that the advantage of SRI over WAI was most marked among patients who did not have MIL ablation, perhaps because MIL ablation may reduce AF recurrences after WAI (see below). It is unclear whether the reduction in AF recurrences was as a result of the additional isolation of the posterior left atrium in SRI, because in previous reports of most patients who had a repeat procedure after either SRI or WAI for recurrent AF, reconnection across ablation lines was nearly always observed, and this was thought to be the mechanism for recurrences. 10, 22 Hence, the reduction in AF recurrences may simply be because of SRI being less susceptible to reconnections. Nevertheless, it is still possible that the additional isolation of the posterior left atrium may still have additional benefit because some patients have AF recurrences although their pulmonary veins remain isolated, presumably because of extravenous drivers of AF. Although the mechanism for fewer AF recurrences with SRI is unclear, our findings again demonstrate that variations in the basic lesion set used in these procedures can significantly impact on clinical outcomes and that further improvements may be possible with refinements of the lesion set used.
In contrast to its effect on AF recurrences, we found that the variation in the isolation techniques studied did not affect OAT recurrences. The incidence of OAT in this study was higher in both groups than that noted in earlier reports of segmental or wide antral pulmonary vein isolation outcomes. 7, 8, 23 Previous studies of SRI have suggested that it may be particularly predisposed to OAT recurrences possibly because a large portion of the left atrium is isolated potentially creating a large obstacle for reentrant circuits. 10 Furthermore, long lines of ablation lesions are laid down, which may also increase the risk of reconnections that are slowly conducting and proarrhythmic. This was not borne out by our study which found that both the SRI and WAI arms had similar rates of OAT recurrence.
Potential Impact of Isolation Technique on Long-Term Outcomes After Repeat Procedures
In this study, we found that although SRI patients had fewer AF recurrences than WAI patients and both groups had similar OAT recurrences of any atrial arrhythmia, the overall survival was similar. This was because there were more patients in the WAI group who had both AF and OAT recurrences. Furthermore, it means that more patients in the SRI group only had OAT recurrences without AF recurrences. This may explain why our earlier observational studies found that a relatively large proportion (34%) of SRI patients had OAT during their redo procedures because their OAT recurrences were not masked by recurrent AF. Of note, it has been recently reported that patients who had recurrent persistent AF had worse outcomes than patients who had recurrent atrial tachycardia after a repeat ablation procedure. 24 Hence, patients who undergo SRI at their initial procedure may have better outcomes after repeat procedures as they may be more likely to have only OAT compared with WAI patients. Given that a large proportion of patients undergoing AF ablation require ≥1 repeat procedures after their initial one, the differing patterns of recurrence after SRI or WAI may influence clinical outcomes in these patients. Whether this will lead to better overall outcomes eventually will need to be confirmed in further studies.
MIL Ablation Has Variable Effect on Recurrences
MIL ablation has been proposed as a means to improve outcomes of ostial or wide antral pulmonary vein isolation for AF. 7, 8 However, it can be difficult to achieve electric block across linear ablations in all patients. Recovery of conduction across these linear ablation lines is also frequently seen in patients with recurrent atrial arrhythmias. 25 Nonetheless, earlier studies were able to demonstrate that the addition of MIL ablation to ostial or wide antral pulmonary vein isolation improved AF-free survival at 1 year, despite successfully achieving bidirectional block in 76% to 92% of patients after ≈25 minutes of ablation, frequently including ablation within the coronary sinus. 7, 8 In contrast, this present study found that the addition of MIL ablation did not improve survival free of any atrial arrhythmia. Instead, there was a nearly significant increase in OAT-free survival with MIL ablation, which was mostly driven by a significant improvement in OAT-free survival among SRI patients. Among WAI patients, we found no effect on OAT recurrence but a nearly significant increase in AF-free survival, in keeping with earlier studies of this isolation technique. 7, 8 A possible reason for the differing effects of MIL ablation on patients who had SRI or WAI could be that recurrent mitral annular flutter is common in patients who have had SRI (24%) and possibly more so than after WAI (4% to 14%). 10, 12, 15 Hence, MIL ablation may have a greater effect on OAT recurrences in these patients. These results have to be interpreted with caution because we achieved a lower rate of complete electric block across the MIL (54%) compared with other studies. This was most likely due to a much less aggressive approach taken to MIL ablation, as evidenced by our much shorter mean ablation times of 11 to 14 minutes, and fewer attempts to ablate within the coronary sinus. The rationale for this approach was to avoid the previously reported complications of cardiac tamponade or coronary artery injury with MIL ablation. 7, 26 The mechanism by which MIL ablation reduces AF recurrences remains uncertain. Possible mechanisms proposed include elimination of mitral isthmus-dependent macroreentrant flutters, ablation of extravenous drivers of AF close to the vein ostia, or ablation of ganglionic plexi in that region. 8, 11, 27, 28 The low rate of achieving electric block in this study may provide some insight into this issue, especially in patients undergoing WAI. We found in this group that electric block of the MIL significantly increased AF-free survival ( Figure 4A ) and survival free of any atrial arrhythmia ( Figure 4C ) compared with patients who had incomplete mitral isthmus ablation or no ablation at all. This is likely to be what accounts for the near-significant improvement in AF-free survival in patients who were randomized to mitral isthmus ablation. Patients with incomplete mitral isthmus ablation did not see a corresponding improvement in AF-free survival, suggesting that electric block rather than ablation of extravenous drivers or ganglionic plexi is responsible for the reduced AF recurrences.
There is evidence that incomplete linear ablations may predispose patients to recurrent arrhythmias, particularly macroreentrant atrial tachyarrhythmias, by creating regions of slow conduction. 11 However, Fassini et al 8 found that patients with unsuccessful MIL ablation had similar recurrence rates to patients who did not have any mitral isthmus ablation. In this study, we also found that unsuccessful ablation did not increase the recurrences of AF or organized atrial arrhythmias, significantly such that the addition of mitral isthmus ablation, successful or otherwise, to WAI resulted in an increased AF-free survival that approached statistical significance but no change in OAT-free survival ( Figure 3A and 3B) .
Of note, mitral isthmus ablation resulted in longer ablation times but not procedure times. However, there was paradoxically shorter fluoroscopy time among these patients. The reason for this is unclear. Generally, fluoroscopy times were long in this study and probably reflect the heavy reliance on fluoroscopy during ablation at our center during the period of our study.
Risk of Esophageal Thermal Injury
Please see the online-only Data Supplement for further discussion.
Limitations
This study included patients with either paroxysmal or persistent AF, although they may differ significantly in terms of their underlying disease substrate and response to therapy. Patients with paroxysmal and persistent AF were included because there were little data on the effect of underlying arrhythmia type on outcomes for patients undergoing single-ring ablation. We, therefore, recruited a cohort that was representative of the patients referred to a tertiary center for AF catheter ablation. In our analyses of the outcomes of patients with paroxysmal or persistent AF, we found that the trends were similar for both subgroups but that they were not statistically significant, probably because of the small cohort size.
Conclusions
SRI resulted in a different mode of recurrence with fewer AF recurrences than WAI, although OAT recurrences and overall atrial arrhythmia recurrences were similar. Whether this may lead to fewer recurrences after repeat procedures is unclear. Adjunctive MIL ablation does not reduce AF recurrences but trends toward fewer OAT recurrences. It seems to affect SRI and WAI patients differently and significantly reduces OAT recurrences only in addition to SRI.
